Evidence map›Paper›PMID 30589864›Full record

ArticlePloS one2018

Ischemia-reperfusion injury in a rat microvascular skin free flap model: A histological, genetic, and blood flow study.

Alberto Ballestín, Javier G Casado, Elena Abellán, F Javier Vela, Verónica Álvarez, Alejandra Usón, Esther López, Federica Marinaro, Rebeca Blázquez, Francisco Miguel Sánchez-Margallo

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05327348 (The Efficacy of Perioperative Parenteral Ascorbic Acid in Reducing Oxidative Stress Among Patients Undergoing Free Flap Reconstructive Surgery), which is not on this map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05327348 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

The Efficacy of Perioperative Parenteral Ascorbic Acid in Reducing Oxidative Stress Among Patients Undergoing Free Flap Reconstructive Surgery: A Prospective Multicenter Randomized Controlled Pilot Trial

TypeinterventionalSponsorUniversity of MalayaRan2022 to 2023Enrolled34ConditionsOxidative Stress, Ischemia-reperfusion InjuryArmsIntravenous Ascorbate, Normal Saline 10 mL Injection
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Alberto BallestínDepartment of Microsurgery, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.ORCID 0000-0002-7150-9758
Javier G CasadoStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Elena AbellánDepartment of Microsurgery, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
F Javier VelaDepartment of Microsurgery, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Verónica ÁlvarezStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Alejandra UsónStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Esther LópezStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Federica MarinaroStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.ORCID 0000-0001-5965-7718
Rebeca BlázquezStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.ORCID 0000-0002-1149-8305
Francisco Miguel Sánchez-MargalloDepartment of Microsurgery, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain.
Centro de Cirugía de Mínima Invasión Jesús Usón · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia reperfusion injury is associated with tissue damage and inflammation, and is one of the main factors causing flap failure in reconstructive microsurgery. Although ischemia-reperfusion (I/R) injury is a well-studied aspect of flap survival, its biological mechanisms remain to be elucidated. To better understand the biological processes of ischemia reperfusion injury, and to develop further therapeutic strategies, the main objective of this study was to identify the gene expression pattern and histological changes in an I/R injury animal model. Fourteen rats (n = 7/group) were randomly divided into control or ischemia-reperfusion group (8 hours of ischemia). Microsurgical anastomoses were objectively assessed using transit-time-ultrasound technology. Seven days after surgery, flap survival was evaluated and tissue samples were harvested for anatomopathological and gene-expression analyses.The I/R injury reduced the survival of free flaps and histological analyses revealed a subcutaneous edema together with an inflammatory infiltrate. Interestingly, the Arginase 1 expression level as well as the ratio of Arginase 1/Nitric oxide synthase 2 showed a significant increase in the I/R group. In summary, here we describe a well-characterized I/R animal model that may serve to evaluate therapeutic agents under reproducible and controlled conditions. Moreover, this model could be especially useful for the evaluation of arginase inhibitors and different compounds of potential interest in reconstructive microsurgery.

Indexed as

MicrovesselsAnimalsBiomarkersDisease Models, AnimalFree Tissue FlapsGene Expression ProfilingGraft SurvivalImmunohistochemistryMaleMicroscopyRatsReperfusion InjurySkin TransplantationUltrasonographyBiomarkers

Identifiers

PMID30589864
PMCPMC6307726
OpenAlexW2906694638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.